http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014133467-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1278
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
filingDate 2013-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2014133467-A
titleOfInvention THERMOSENSITIVE COMPOSITIONS IN THE TYPE OF NANOPARTICLES AND METHOD FOR PRODUCING THEM
abstract 1. A liposome preparation containing a suspension of liposomes containing a gel lipid bilayer and an active agent enclosed within liposomes, wherein said lipid bilayer contains: (i) one or more phospholipids selected from the group consisting of phosphatidylcholines, phosphatidylglycerols, phosphatidylinositols and phosphatidylinositols; ii) one or more phospholipids derivatized with a hydrophilic polymer; and (iii) one or more lysolipids selected from the group consisting of monoacylphosphatidylglycerols, monoacylphosphatidylglycerols, monoacylphosphatidylinositols, monoacylphosphatidyl ethanolamines, wherein the active agent is selected from the group consisting of doxacorubinodinocin dicarubin dicarubicin dicarubicin dicarubicin dicarubicin dicarubicin dicarubin azin , mitomycin, mitoxantrone, vinblastine, vinorelbine and vincristine, and wherein the components of the lipid bilayer are represented in a molar ratio of about 80-90: 2-8: 2-18; and wherein the liposomes in suspension have a size of from about 50 to about 150 nm. 2. The liposome preparation according to claim 1, characterized in that the active agent is doxorubicin, the relative concentration of impurity A after 6 months of storage at a temperature of less than or equal to 8 ° C is less than 0.5%, and impurity A forms a peak with relative a retention time of about 1.4 when analyzed by high performance liquid chromatography (HPLC) on a C18 column with a reversed phase when eluting with a gradient of acetic acid / methanol. 3. A liposome preparation according to claim 2, characterized in that the relative concentration of impurity A after 6 months of storage at a temperature of less than or equal to 8 ° C is less than 0.2%. 4. The liposome preparation according to claim 2, characterized
priorityDate 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID452110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124516887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426078412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447827115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426070748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44424639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID457193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426259713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24779552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941

Total number of triples: 65.